Keylicon Biosciences Unveils Revolutionary RNA Technology to Transform Therapeutics Keylicon Biosciences announces exclusive rights to next-gen RNA technology that promises to revolutionize vaccine and therapeutic development, enhancing protein expression and lowering immune response.

Keylicon Biosciences Unveils Revolutionary RNA Technology to Transform Therapeutics #United_States #Boston #Keylicon_Biosciences #Boston_University #RNA_Technology